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Dermatomyositis (DM) is an idiopathic inflammatory myopathy with characteristic
cutaneous manifestations, such as erythematous papules on the dorsal surface of
the phalangeal joints (Gottron’s sign), edematous erythema of the eyelids
(heliotrope erythema), and a violaceous, erythematous rash on the trunk.
1
Malignancy may occur before the onset of myositis, concurrently or afterwards.
The most commonly observed cancers in female patients with DM are breast and
gynecologic cancers, whereas the most commonly observed cancer in male
patients with DM is lung cancer. The most commonly observed cancer shared by
both genders is gastrointestinal cancer.
1 The risk of malignancy in DM patients
increases for 3-5 years after the onset of DM and then decreases to near baseline,
and a true link with cancer does exist.
2 Worldwide, only one case of tonsillar
cancer associated with DM has been reported in Italy.
3 We report two cases of
Korean patients with DM and tonsillar squamous cell carcinoma. 
Case 1
A 61-year-old woman born in South Korea was referred to the Department of
Otorhinolaryngology-Head and Neck Surgery on December 2005 because of a
sore throat and left cervical lymphadenopathy that was first noticed by the patient
in September 2005.  
The patient was diagnosed with DM in September 2004 and was subsequently
followed by a rheumatologist. She was noted to have a heliotrope rash on the
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Dermatomyositis (DM) is an autoimmune disorder with idiopathic myopathy and
characteristic skin manifestations that one often accompanied by an internal
malignancy. The association between dermatomyositis and malignancy has been
reported several times, although tonsillar carcinoma is extremely rare not only in
far eastern populations but also in caucasian populations. We report two cases of
Korean patients with dermatomyositis associated with tonsillar carcinoma. 
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INTRODUCTION
CASE REPORTeyelids and a red, violaceous, non-pruritic skin rash on her
trunk, and symmetrical proximal muscle weakness. The
clinical features of DM were supported by several labo-
ratory tests. The patient had elevated muscle enzymes as
demonstrated by increased CK (1609 U/L), serum myo-
globin (548 ng/mL), LDH (485 U/L), ESR (45 mm/h), and
C-reactive protein (1.6 mg/dL). Antinuclear antibodies
(ANA) were positive at a lower titer (1 : 160) in Hep-2
cells with a “speckled” morphology on indirect immuno-
fluorescence. Based on the above data, this patient was
diagnosed with probable DM. Initially, oral treatment with
prednisolone and azathioprine was carried out. The oral
prednisolone was tapered off when remission occurred. 
On the initial visit to our department in December 2005,
pharyngeal endoscopy demonstrated a vegetation on the left
palatine tonsil. A surgical biopsy revealed that the lesion
was squamous cell carcinoma. A non-tender, hard, and non-
movable mass was palpated in the left neck. A neck CT with
enhancement revealed multiple pathologic lymph nodes in
the left upper internal jugular chain (level II) and a primary
lesion on the left palatine tonsil (Fig. 1). The preoperative
cancer evaluation included a neck MRI, a bone scan,
gastroscopy, an abdominal sonogram, and a chest X-ray.
The tumor status was reported as stage IVa, cT1N2bM0. 
The patient underwent three courses of neoadjuvant
chemotherapy with cisplatin and 5-fluorouracil with a
good response. One month after the end of this treatment,
surgical treatment with wide excision of the left tonsil
cancer via a midline mandibulotomy approach with an
ipsilateral modified radical neck dissection was performed.
Histology of the surgical specimens from the neck dissec-
tion and primary lesion showed squamous cell carcinoma.
The patient received concurrent chemoradiotherapy (CCRT);
the oral prednisolone and azathioprine had been discon-
tinued. Her muscle enzyme levels were normalized 6
months after the surgical treatment. However, multiple
pulmonary metastatic lesions were found on PET CT in
March 2007 and she died of pulmonary edema and an
embolism in August 2007.
Case 2
A 64-year-old man born in South Korea was referred to the
Department of Otorhinolaryngology-Head and Neck
Surgery in March 2007 because of a right neck mass. The
mass was diagnosed as a carcinoma by fine needle aspira-
tion cytology (FNAC). He was diagnosed with DM in
August 2005 at the Department of Rheumatology. The
characteristics of DM were supported by physical findings,
such as heliotrope erythema, a Gottron’s papule, symmetri-
cal proximal muscle weakness, and several laboratory
studies. The laboratory findings included elevated muscle
enzymes, as demonstrated by increased CK (2606 U/L),
serum myoglobin (608 ng/mL), LDH (612 U/L), and ESR
(50 mm/h). ANA were positive at a lower titer (1 : 80) on
Hep-2 cells with a “speckled” morphology on indirect
immunofluorescence. Based on the above findings, this
patient was diagnosed with probable DM. At follow-up, the
DM was treated with steroids and an immunosuppressant
agent at the Department of Rheumatology. 
Physical examination demonstrated no primary origin
for the malignancy. A non-tender, hard, and non-movable
mass was palpated in the right neck (cervical lymph node
level II). A neck CT with enhancement revealed a predo-
minantly solid mass in the right parapharyngeal space at
the level of the oropharynx (Fig. 2). An FNAC reported
the presence of atypical cells. A PET CT was performed to
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Fig. 1. Axial view of the neck CT with enhancement revealed multiple pathologic
lymph nodes of the left upper internal jugular chain and cervical lymph node
group II (black arrow) and a primary lesion of the left palatine tonsil (white arrow). 
Fig. 2. Neck CT with enhancement revealed a predominantly solid mass in the
right parapharyngeal space at the level of the oropharynx.identify the primary cancer site. 
18F-fluorodeoxyglucose
(
18F-FDG) uptake was increased in the right palatine tonsil
and right parapharyngeal space (max SUV of 4.4 and 1.4,
respectively) (Fig. 3). 
Panendoscopic biopsies were obtained at four suspicious
primary sites (the hypopharynx, base of the tongue, tonsils,
and nasopharynx). The primary site was shown to be the
right palatine tonsil. The tumor status was reported as
cT1N1M0. Surgical treatment with wide excision of the
right tonsil cancer and right modified radical neck dissec-
tion was performed. The surgical biopsy revealed squa-
mous cell carcinoma. His muscle enzyme levels were
normalized 6 months after the surgical treatment. During
subsequent 14 months of follow-up, no signs of malig-
nancy recurred and the muscle enzyme levels were persis-
tently normal. 
DM should be considered an autoimmune disorder in which
genetic and environmental factors, such as neoplastic
antigens, seem to play a determinant pathogenic role in
inducing dysregulation of the immune system.
3,4
Although the temporal relationship between DM and
malignancy remains unclear, coincidental observations
have been found in all body areas. Ovarian, lung, and
colorectal cancers have been diagnosed frequently both
before and after the diagnosis of DM, suggesting that these
are candidate cancers for association with the disease.
4 The
clinical manifestations of DM have been reported to imp-
rove after treatment of underlying cancer, however, the
tumor prognosis is not affected by DM since the survival
rate is similar to cases without DM.
5 In addition, muscle
weakness has been shown with relapses of the malig-
nancy.
6 Therefore, surveillance needs to be maintained
because the risk of malignant disease remains high for
many years after diagnosis. An evaluation for malignancy
in patients with DM could potentially reduce mortality. 
In the two cases presented in this paper, one patient died
of metastatic disease of the lungs 17 months after surgery
and CCRT while the other patient has survived for 14
months after surgery. The prognoses of the patients report-
ed herein are similar to other reports,
6 suggesting that
survival rates are comparable to cases without DM. Thus,
the progression of cancer does not appear to change with
treatment of the DM.
In conclusion, from the viewpoint of otolaryngologists,
careful examination of the upper airway and digestive tract
is important for screening and detection of a malignancy in
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DISCUSSION
Fig. 3. FDG uptake was increased in the right palatine tonsil and right parapharyngeal space with a max SUV of 4.4 and 1.4, respectively. FDG,
fluorodeoxyglucose; SUV,  standard uptake value.Sung Wan Kim, et al.
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patients with DM, because survival can be prolonged and
disability from myositis can be alleviated if cancers are
treated early.  
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